SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Amendment No. 1 to
FORM 11-K
ý ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2001
or
o TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Commission file number: 1-10378
A. Full title of the plan and the address of the plan, if different from that of the issuer named below:
Aventis Bio-Services Inc. Employee Savings Plan
1020 First Avenue
P.O. Box 61501
King of Prussia, Pennsylvania 19406
B. Name of issuer of the securities held pursuant to the plan and the address of its principal executive office:
Aventis
67917 Strasbourg cedex 9
France
AVENTIS BIO-SERVICES, INC.
EMPLOYEE SAVINGS PLAN
Financial Statements as of and for the years ended December 31, 2001 and 2000 |
|
Additional information required for Form 5500 for the year ended December 31, 2001 |
AVENTIS BIO-SERVICES, INC. EMPLOYEE SAVINGS PLAN
Table of Contents
* Other supplemental schedules required by Section 2520.103-10 of the Department of Labor Rules and Regulations for Reporting and Disclosure under ERISA have been omitted because they are not applicable.
1
Report of Independent Auditors
To the Participants and Administrator of
Aventis Behring L.L.C. Employee Savings Plan
In our opinion, the accompanying statements of net assets available for benefits and the related statements of changes in net assets available for benefits present fairly, in all material respects, the net assets available for benefits of Aventis Behring L.L.C. Employee Savings Plan (the “Plan”) at December 31, 2001 and 2000, and the changes in net assets available for benefits for the years then ended in conformity with accounting principles generally accepted in the United States of America. These financial statements are the responsibility of the Plan’s management; our responsibility is to express an opinion on these financial statements based on our audits. We conducted our audits of these statements in accordance with auditing standards generally accepted in the United States of America, which require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
Our audits were conducted for the purpose of forming an opinion on the basic financial statements taken as a whole. The supplemental schedule of assets (held at end of year) is presented for the purpose of additional analysis and is not a required part of the basic financial statements, but is supplementary information required by the Department of Labor’s Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974. This supplemental schedule is the responsibility of the Plan’s management. The supplemental schedule has been subjected to the auditing procedures applied in the audits of the basic financial statements and, in our opinion, is fairly stated in all material respects in relation to the basic financial statements taken as a whole.
/s/ PricewaterhouseCoopers LLP | |
|
Philadelphia, PA |
June 13, 2002 |
2
AVENTIS BIO-SERVICES, INC. EMPLOYEE SAVINGS PLAN
Statements of Net Assets Available for Benefits as of December 31, 2001 and 2000
| | As of December 31, | |
| | 2001 | | 2000 | |
ASSETS | | | | | |
| | | | | |
Investments, at fair value | | | | | |
Registered investment companies: | | | | | |
Janus Worldwide Fund | * | $ | 1,866,908 | * | $ | 2,371,760 | |
T. Rowe Price Equity Income Fund | | 425,267 | | 300,706 | |
Vanguard 500 Index Fund | * | 2,751,898 | * | 3,088,751 | |
Vanguard Federal Money Market Fund | * | 3,535,995 | * | 3,298,196 | |
Vanguard International Growth Fund | | 419,557 | | 438,919 | |
Vanguard PRIMECAP Fund | * | 2,532,574 | * | 2,940,464 | |
Vanguard Small-Cap Index Fund | | 795,620 | | 690,496 | |
Vanguard Total Bond Market Index Fund | | 647,751 | | 405,443 | |
Vanguard U.S. Growth Fund | * | 1,882,388 | * | 2,384,029 | |
Vanguard Wellington Fund | * | 1,542,501 | * | 1,504,500 | |
Vanguard Windsor II Fund | | 857,918 | | 684,637 | |
| | 17,258,377 | | 18,107,901 | |
Aventis S.A. Stock Fund | | 323,948 | | 208,687 | |
Participant Loans | * | 1,342,103 | * | 1,229,030 | |
| | 18,924,428 | | 19,545,618 | |
Investments, at contract value | | | | | |
Aventis Interest Income Fund | * | 6,111,680 | * | 5,426,047 | |
Total investments | | 25,036,108 | | 24,971,665 | |
| | | | | |
Receivables | | | | | |
Employer's contributions | | 105,651 | | 49,369 | |
Participant's contributions | | 125,885 | | 99,066 | |
Loan repayment | | 7,976 | | 7,446 | |
Total receivables | | 239,512 | | 155,881 | |
| | | | | |
TOTAL ASSETS | | 25,275,620 | | 25,127,546 | |
| | | | | |
LIABILITIES | | | | | |
Contributions owed to participants | | 57 | | 16,666 | |
| | | | | |
NET ASSETS AVAILABLE FOR BENEFITS | | $ | 25,275,563 | | $ | 25,110,880 | |
* Represents 5% or more of net assets available for benefits.
The accompanying notes are an integral part of the financial statements.
3
AVENTIS BIO-SERVICES, INC. EMPLOYEE SAVINGS PLAN
Statements of Changes in Net Assets Available for Benefits for the Years Ended December 31, 2001 and 2000
| | Year Ended December 31, | |
| | 2001 | | 2000 | |
Additions | | | | | |
Investment income: | | | | | |
Interest and dividend income, investments | | $ | 869,033 | | $ | 2,028,175 | |
Net depreciation in fair value of investments | | (2,404,228 | ) | (2,367,393 | ) |
| | (1,535,195 | ) | (339,218 | ) |
Contributions: | | | | | |
Employer | | 801,081 | | 617,083 | |
Participant | | 1,526,502 | | 1,255,052 | |
| | 2,327,583 | | 1,872,135 | |
Asset transfers in | | 1,203,652 | | — | |
Other additions | | 15 | | 56 | |
Total additions | | 1,996,055 | | 1,532,973 | |
| | | | | |
Deductions | | | | | |
Payment of benefits | | 1,828,992 | | 2,418,684 | |
Other deductions | | 2,380 | | 1,396 | |
Total deductions | | 1,831,372 | | 2,420,080 | |
| | | | | |
Net increase/(decrease) | | 164,683 | | (887,107 | ) |
| | | | | |
Net assets available for plan benefits: | | | | | |
Beginning of year | | 25,110,880 | | 25,997,987 | |
End of year | | $ | 25,275,563 | | $ | 25,110,880 | |
The accompanying notes are an integral part of the financial statements.
4
NOTE 1 - DESCRIPTION OF PLAN
The following description of Aventis Bio-Services, Inc. Employee Savings Plan (originally known as the Centeon Bio-Services, Inc. Employee Savings Plan), or the “Plan”, is provided for general information purposes. Participants should refer to the Plan agreement for a more complete description of the Plan’s provisions.
General
The Plan is a voluntary, defined contribution 401(k) plan for salaried and hourly employees of Aventis Bio-Services, Inc (the “Company”). The Plan is subject to the provisions of the Employee Retirement Income Security Act of 1974 (“ERISA”).
Employees are eligible to join the Plan following the completion of one year of service and the attainment of 21 years of age.
The Employee Savings Plan Investment Committee, as appointed by the Company’s Chief Financial Officer, is the Plan’s investment fiduciary. The Employee Savings Plan Committee (the “Committee”), as appointed by the Company’s Senior Vice President of Human Resources, is responsible for the general administration of the Plan.
On August 21, 2000, the Company acquired Seramed, Inc (“Seramed”), which is engaged in the business of operating plasma collection centers throughout the United States. The Aventis Bio-Services, Inc. employees in certain Seramed centers were eligible to begin participating in the Plan beginning October 1, 2000 and also had the option of transferring their account balances from the Seramed 401 (k) plan at that time. As of June 13, 2001, the Company’s Board of Directors approved a resolution to merge the Aventis Bio-Services Inc 401(k) Retirement Savings Plan for Former Serologicals, Inc Employees into the Plan effective July 1, 2001. Effective August 7, 2001 all funds and related participant account balances were transferred from the Aventis Bio-Services Inc. 401(k) Retirement Savings Plan for Former Serologicals, Inc Employees to the Plan. As a result, approximately $1,203,652 in net assets was transferred into the Plan.
Contributions
All participant contributions are made on a before-tax basis. Each participant may invest from 1% to 6% of annual basic compensation (on which the employer match applies) as a basic contribution. In addition, each participant may make an additional supplemental contribution up to 9%, subject to certain limitations. The total of the basic and supplemental contributions cannot exceed IRS limitations for each plan year. For the 2001 and 2000 plan years, the total of such contributions cannot exceed $10,500. If a participant’s annual contributions exceed the dollar limitation set by the IRS, thereby requiring a distribution of such excess contributions, the participant will forfeit any employer contributions related to the distribution amount. Amounts forfeited will be used to reduce future employer contributions.
Prior to January 1, 2001, employees earning $80,000 or more annually were subject to a $3,000 limit on the employer matching contribution. Effective January 1, 2001, the Plan eliminated the $3,000 limit on the employer matching contribution for employees whose annual earnings are $80,000 or more. Employer matching contributions for all other employees do not have a limit.
Employee rollover contributions from other qualified retirement plans are permitted; such contributions are subject to the conditions and procedures set forth in the Plan.
The Company’s basic matching contribution for plan participants is as follows:
Portion of 6% Basic Contribution | | Company Contribution Percentage | |
| | | |
1st-3rd | 1% | | | 100 | % |
4th-5th | 1% | | | 50 | % |
6th | 1% | | | 20 | % |
5
Participant Accounts
Each participant’s account is credited with the participant’s contribution and allocations of the Company’s contribution and Plan earnings. Allocations are based on participant earnings or account balances, as defined. The benefit to which a participant is entitled is the benefit that can be provided from the participant’s vested account.
Vesting
Upon enrollment of the Plan, participants are fully vested at all times in all amounts held in their accounts.
Participant Loans
Any participant who is an employee may apply for a secured loan provided the request does not exceed 50% of his vested account value and the total outstanding does not exceed $50,000. The minimum loan amount is $1,000. Only one loan may be made every 365 days and all loans are subject to approval by the Committee. Loan terms are limited to five years for general loans and ten years for loans relating to the primary residence of the participant with no penalty for early repayment. Interest rates are determined by the Committee in accordance with prevailing market rates on similar types of loans, ranging between 6.75% and 14.75% at December 21, 2001. Interest paid by the participant is credited to the participant’s account. If a participant defaults on an outstanding loan, the unpaid amount is treated as a taxable withdrawal and is subject to the ten percent surtax (prior to age 59 ½) and federal income taxes.
When a participant receives a distribution from the Plan, any outstanding principal plus accrued interest will be deducted from the amount of the distribution. A participant may then either default on the loan or make arrangements to continue loan repayments beyond when he becomes entitled to a distribution as long as his remaining interest in the Plan exceeds his outstanding loan balance.
Payment of Benefits
If a participant retires, dies, becomes permanently disabled, or otherwise separates from the Company, the participant or participant’s beneficiary is entitled to the full amount of his account as valued on the applicable valuation date. In the event of a participant’s death, distribution of his account will be made as soon as administratively practicable upon the receipt of appropriate documentation from his designated beneficiary. Distributions for reasons of retirement, permanent disability or termination will be made upon written request. Distributions of a participant’s account are typically made in a single payment. However, distributions for reasons other than death may be made under a withdrawal method at the discretion of the Committee. Deferrals of distributions cannot be made past the age of 70 ½.
While employed, a participant may make certain withdrawals upon written notice of (1) employer contributions which are held in investment vehicles and which have been held in such vehicles for at least 2 years and (2) basic and supplemental contributions for the reason of financial hardship, as defined in the Plan. Hardship withdrawals must be approved by the Committee. At the age of 59 ½, the participant may withdraw any portion of his basic and supplemental contribution amounts.
Before-tax contributions, Company matching and supplemental contributions, and all investment earnings are fully taxable upon distribution to the participant. Special lump-sum distribution rules apply for full plan withdrawals made after age 59 ½. A ten percent surtax, as well as a twenty percent mandatory withholding, is applicable to taxable withdrawals and distributions prior to age 59 ½, subject to certain exceptions.
6
Plan Termination
The Company’s Board of Directors may amend or suspend the Plan and may terminate the Plan at any time; although there is no present intent to do so. However, no such action may cause the participants’ employee and Company contribution accounts to be used for purposes other than the exclusive benefit of the participants and their beneficiaries. If the Plan is terminated with respect to all participants or a group of participants, all such participants accounts shall become fully vested and all accounts of participants shall be distributed as soon as administratively possible.
Investment Options
All investments are participant directed. During the plan years ending December 31, 2001 and 2000, participants were able to allocate their contributions, in 1% increments, among the following investment options:
Janus Worldwide Fund
T. Rowe Price Equity Income Fund
Vanguard 500 Index Fund
Vanguard Federal Money Market Fund
Vanguard International Growth Fund
Vanguard PRIMECAP Fund
Vanguard Small-Cap Index Fund
Vanguard Total Bond Market Index Fund
Vanguard U.S. Growth Fund
Vanguard Wellington Fund
Vanguard Windsor II Fund
Aventis Interest Income Fund
Aventis S.A. Stock Fund (new option available beginning July 2000)
Participants may change their investment options at any time.
NOTE 2 - SUMMARY OF ACCOUNTING POLICIES
The following accounting policies, which conform with accounting principles generally accepted in the United States of America, have been used consistently in the preparation of the Plan’s financial statements:
Basis of Accounting
The financial statements of the Plan are prepared on the accrual method of accounting.
Use of Estimates
The preparation of financial statements, in conformity with accounting principles generally accepted in the United States of America, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as reported amounts of additions and deductions during the reporting period. Actual results could differ from those estimates.
Investment Valuation and Income Recognition
Guaranteed Investment Contracts are stated at contract value (cost plus interest income earned on a daily accrual basis) which approximates fair value (Note 3). Shares of registered investment companies are valued at quoted market prices which represent the net asset value of shares held by the Plan at year-end. The Aventis S.A. Stock Fund is valued at its year end unit closing price (comprised of common stock market price plus uninvested cash position). Participant loans are valued at cost, which approximates fair value.
7
Purchases and sales of investments are recorded on a trade-date basis. Interest income is accrued when earned. Dividend income is recorded on the ex-dividend date. Capital gain distributions are included in dividend income.
Payment of Benefits
Benefits are recorded when paid.
Forfeited Accounts
At December 31, 2001 forfeited nonvested accounts totaled $2. These accounts will be used to reduce future employment contributions. Also, in 2001, employer contributions were reduced by $4,102 from forfeited nonvested accounts.
NOTE 3 - INVESTMENT CONTRACT WITH INSURANCE COMPANIES
The Aventis Interest Income Fund (the “Fund”) consists of guaranteed investment contracts with various insurance companies (“Issuers”). Additionally, the fund holds shares of the Vanguard Retirement Savings Trust, a collective trust fund sponsored by the Vanguard Group with a value of $15,888,942 and $8,949,755 at December 31, 2001 and 2000 respectively. The Fund was created as a vehicle for the Plan and Aventis Behring L.L.C. Employee Savings Plan to invest in guaranteed investment contracts. The Plan owns an undivided interest in the Fund, which totaled $6,111,680 and $5,426,047 at December 31, 2001 and 2000, respectively. The Fund is credited with earnings on the underlying investments and charged for Plan withdrawals and administrative expenses charged by the Issuers. The investment contracts included in the Fund are carried at contract value, which approximates fair value, because the contracts are fully benefit responsive. There are no reserves required against contract value for credit risk of the contract issuer or otherwise. The total fair value of the Fund at December 31, 2001 and 2000 is $26,264,274 and $23,037,535, respectively. The crediting interest rates of the investment contracts range from 5.90% to 7.13% at December 31, 2001. Beginning in 1998, certain contracts began to mature. At maturity, the proceeds will be invested in the Vanguard Retirement Savings Trust, invested primarily in investment contracts issued by insurance companies and commercial banks which seeks stability of principle and a high level of current income consistent with a two to three year average maturity.
NOTE 4 - INVESTMENTS
During 2001 and 2000, the Plan’s investments (including gains and losses on investments bought and sold, as well as held during the year) appreciated (depreciated) in value as follows:
| | 2001 | | 2000 | |
| | | | | |
Registered Investment Companies | | $ | (2,376,251 | ) | $ | (2,400,076 | ) |
Common Stock | | (27,977 | ) | 32,683 | |
| | | | | |
| | $ | (2,404,228 | ) | $ | (2,367,393 | ) |
NOTE 5 - RELATED PARTY TRANSACTIONS
Certain Plan investments are shares of mutual funds and a collective trust fund managed by an affiliate of Vanguard Fiduciary Trust Company (“VFTC”). VFTC is the trustee as defined by the Plan. The Plan also
8
invests in shares of Aventis S.A.’s stock through the Aventis S.A. Stock Fund. Transactions in such investments qualify as party-in-interest transactions that are exempt from the prohibited transaction rules.
As discussed in Note 3, the Plan participates with Aventis Behring L.L.C. Employee Savings Plan in the Aventis Interest Income Fund, an investment option available to both companies’ participants.
NOTE 6- PLAN EXPENSES
All costs and expenses, exclusive of fees for participant loans, incurred in the administration of the Plan (i.e., trustee and recordkeeper fees) are currently paid by the Company.
NOTE 7 -TAX STATUS
The Internal Revenue Service has determined and informed the Company by letter dated May 25, 2000 that the Plan was qualified under Internal Revenue Code (“IRC”) Section 401(a). The Plan has subsequently been amended and restated since receiving the determination letter. The Plan has filed an application for a new determination letter, which is currently pending. However, the Company believes the Plan is designed and is currently being operated in compliance with the applicable requirements of the IRC.
NOTE 8 - SUBSEQUENT EVENTS
Effective February 1, 2002, the Plan was amended in order to (i) allow participants who are age 50 and older to make “catch up” contributions to the Plan as permitted by the Economic Growth and Tax Relief Reconciliation Act of 2001 (EGTRRA); and (ii) to increase the maximum deferral percentage under the Plan from 15% to 50%.
On February 20, 2002, Aventis announced that it had signed a non-binding letter of intent with Bayer AG as a preliminary step toward the potential combination of their respective therapeutic blood plasma businesses, Aventis Behring and Bayer Biological Products. According to the terms of this letter of intent, the combined business would be jointly owned by Aventis and Bayer, with Bayer holding the majority stake. As a minority shareholder, Aventis was granted an option to sell its minority stake to Bayer at a later stage. It is the goal of both companies that the combined business would begin operation as a new company in early 2003, subject to the necessary shareholder and regulatory approvals.
9
Required for Form 5500
10
AVENTIS BIO-SERVICES, INC. EMPLOYEE SAVINGS PLAN | Schedule I |
| | | |
Schedule of Assets (Held at End of Year) |
As of December 31, 2001 |
| | |
Aventis Bio-Services, Inc. Employee Savings Plan— EIN 62-1044012 |
| | | |
Attachment to Form 5500, Schedule H, Part IV, Line i: |
| | | |
| Identity of Issue | | Investment Type | | Current Value |
| Janus Worldwide Fund | | Registered Investment Company | | $ | 1,866,908 |
| T. Rowe Price Equity Income Fund | | Registered Investment Company | | 425,267 |
* | Vanguard 500 Index Fund | | Registered Investment Company | | 2,751,898 |
* | Vanguard Federal Money Market Fund | | Registered Investment Company | | 3,535,995 |
* | Vanguard International Growth Fund | | Registered Investment Company | | 419,557 |
* | Vanguard PRIMECAP Fund | | Registered Investment Company | | 2,532,574 |
* | Vanguard Small-Cap Index Fund | | Registered Investment Company | | 795,620 |
* | Vanguard Total Bond Market Index Fund | | Registered Investment Company | | 647,751 |
* | Vanguard U.S. Growth Fund | | Registered Investment Company | | 1,882,388 |
* | Vanguard Wellington Fund | | Registered Investment Company | | 1,542,501 |
* | Vanguard Windsor II Fund | | Registered Investment Company | | 857,918 |
* | Aventis S.A. Stock Fund | | Company Stock Fund | | 323,948 |
| Participant Loans | | 6.75—14.75% | | 1,342,103 |
* | Interest in Aventis Interest Income Fund (23.3%) | | | | |
| The Pacific Mutual Life Insurance Company (6.83%, 1/15/03) | | Unallocated Insurance Contract | | 2,751,469 |
| The Principle Mutual Life Insurance Company (6.09%, 1/15/03) | | Unallocated Insurance Contract | | 2,102,746 |
| The Principle Mutual Life Insurance Company (6.69%, 1/15/04) | | Unallocated Insurance Contract | | 2,063,846 |
| The Principle Mutual Life Insurance Company (7.13%, 1/15/04) | | Unallocated Insurance Contract | | 1,483,857 |
| Transamerica Occidental Life Insurance Company (5.9%, 1/15/02) | | Unallocated Insurance Contract | | 1,975,594 |
| Vanguard Retirement Savings Trust | | Common/Collective Trust | | 15,888,942 |
11
AVENTIS BIO-SERVICES, INC. EMPLOYEE SAVINGS PLAN
Schedule of Nonexempt Transactions
Year Ended December 31, 2001 | | Schedule II |
| | |
Aventis Bio-Services, Inc. Employee Savings Plan- EIN 62-1044012 | | |
| | |
Attachment to Form 5500, Schedule G, Part III: | | |
Identity of Party Involved | | Relationship of Plan, Employer, or Other Party In-Interest | | Description of Transactions Including Maturity Date, Rate of Interest, Collateral, Par or Maturity Value | | Purchase Price | | Curret Value of Asset | |
Aventis Bio-Services, Inc. 401(k) Retirement Savings Plan for Former Serologicals, Inc. Employee | | Plan Merger | | Insufficient asset transfer-in, effective 8/7/2001. | | $ | 14,775 | * | $ | 14,775 | |
| | | | | | | | | | | |
* This represents total amount of contributions that have been withheld from employees and corresponding employer match that
was not remitted timely into trust by the plan sponsor.
12
SIGNATURES
The Plan. Pursuant to the requirements of the Securities Exchange Act of 1934, the Plan has duly caused this annual report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | AVENTIS BIO-SERVICES, INC. EMPLOYEE SAVINGS PLAN |
| | | | |
| | | | |
Date: | August 16, 2002 | | By: | /s/ Raymond Regan | |
| | | | Raymond C. Regan, Plan Administrator |
13
EXHIBIT INDEX
Exhibit | | Description | |
| | | |
23.1 | | Consent of PricewaterhouseCoopers LLP to incorporation by reference in the Registration Statement on Form S-8 of Aventis and the Aventis Bio-Services Inc. Employee Savings Plan of their report dated August 16, 2002, relating to the financial statements of the Aventis Bio-Services, Inc. Employee Savings Plan, which appears herein. | |
14